Developer docs
API playgroundTry for free, no card

Search company profiles

Phenox Inc

Full company profile

uuid02lrhs8

Namestring
Phenox Inc
Legal namestring
phenox Inc.
Websiteurl
phenox.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Phenox Inc. is the US distribution subsidiary of phenox GmbH, a privately-held medical device company founded in 2005 and headquartered in Bochum, Germany. The company develops and distributes interventional devices for the treatment of neurovascular diseases, with a particular focus on acute ischemic stroke, hemorrhagic stroke, and complex intracranial aneurysms. Its US operations are headquartered in Irvine, California, with manufacturing executed through two partners: Wallaby Medical in Laguna Hills, California (producing Avenir, Esperance, Pilote, and pNOVUS 17) and phenox Limited in Galway, Ireland (producing pRESET, pNOVUS 21, and pORTAL).

The product portfolio is structured as an integrated treatment ecosystem across three clinical categories. Acute ischemic stroke devices include the pRESET mechanical thrombectomy device (helical slit design with dual-type cells for clot integration) and the Esperance Aspiration Catheter. Hemorrhagic stroke is addressed via the Avenir Coil System and Avenir Uno (handle-free detachment, 62 ultra-soft coil sizes). Access and delivery devices — pNOVUS Microcatheter, pORTAL 14 Microguidewire (ASACOR torque technology), Pilote Long Sheath, and Esperance Distal Access Catheter — are designed for navigation in tortuous anatomies. Aneurysm treatment is supported by the p64 Flow Modulation Device and pCONUS Bifurcation Aneurysm Implant.

Phenox generates revenue through direct hardware sales of these devices to hospitals, stroke treatment centers, and endovascular specialists, with distribution in the United States handled exclusively through phenox Inc. The company employs an enterprise field sales motion, supported by marketing activity at medical conferences and industry events, and operates alongside affiliated entities under the "WallabyPhenox" brand umbrella.

Short descriptiontext

Phenox Inc. is the US distribution arm of phenox GmbH, a privately-held medical device company that develops and sells a portfolio of neurovascular interventional devices — including mechanical thrombectomy, aspiration catheters, embolic coils, and access devices — directly to hospitals and endovascular specialists for treating ischemic and hemorrhagic stroke.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurovascular medical devices, mechanical thrombectomy devices, embolization coil systems, stroke treatment devices, microcatheter access devices
Industry2 codes
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAKAIAG
Stroke & Vascular Neurology
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Neurovascular Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Neurovascular Medical Device Sales
TypeHardware Sales
Description

Phenox generates revenue through the sale of medical devices for treating neurovascular diseases including thrombectomy devices, aneurysm implants, aspiration catheters, microcatheters, and guidewires. Products are sold to hospitals and endovascular specialists performing stroke procedures.

phenox.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Phenox develops, manufactures, and distributes neurovascular interventional devices for the treatment of ischemic and hemorrhagic stroke, intracranial aneurysms, and dissections. The portfolio includes mechanical thrombectomy devices (pRESET), aspiration catheters (Esperance), embolic coil systems (Avenir, Avenir Uno), flow modulation and bifurcation implants (p64, pCONUS), and access/delivery devices (pNOVUS, pORTAL, Pilote, Esperance Distal Access Catheter). Products are sold to hospitals and endovascular specialists performing neurovascular procedures.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Phenox Inc is a medical device company specializing in neurovascular treatments for stroke. The product portfolio consists of a comprehensive suite of interventional devices organized into three main categories: Acute Ischemic Stroke Devices (thrombectomy and aspiration catheters including pRESET and Esperance Aspiration Catheter), Hemorrhagic Stroke Devices (coiling systems including Avenir Coil System and Avenir Uno), and Access Devices (microcatheters, microguidewires, and sheaths including pNOVUS, pORTAL, Pilote Long Sheath, and Esperance Distal Access Catheter). Additionally, the company offers advanced aneurysm treatment devices including the p64 Flow Modulation Device and pCONUS Bifurcation Aneurysm Implant. These devices work together as an integrated treatment ecosystem where access devices facilitate navigation to treatment sites, and treatment devices address the specific stroke pathology.

Product and service10 records
1Esperance Aspiration Catheter
CategoryAcute Ischemic Stroke Device
Description

Aspiration catheter designed for acute ischemic stroke treatment, used by endovascular specialists to remove blood clots from cerebral arteries through suction-based thrombectomy procedures.

2pRESET Thrombectomy Device
CategoryAcute Ischemic Stroke Device
Description

Mechanical thrombectomy device with a helical slit design, proximal closed ring, and dual type cells for clot integration and retrieval in tortuous anatomies, used for acute ischemic stroke treatment.

3Avenir Coil System
CategoryHemorrhagic Stroke Device
Description

Embolic coil system for aneurysm treatment featuring a handle-free instant detachment mechanism, ultra soft coils with 62 sizes of unparalleled softness, a complete portfolio of 7 versatile softness classes, 2 shapes, and 2 coil diameters.

4Avenir Uno Embolic Coils
CategoryHemorrhagic Stroke Device
Description

Embolic coils designed for small diameters and longer lengths, featuring purpose-built precision coil shapes, finisher softness for dense packing, and procedural efficiency in small spaces.

5Esperance Distal Access Catheter
CategoryAccess Device
Description

Distal access catheter for accessing cerebral vasculature during neurovascular procedures, providing support and trackability for device delivery.

6Pilote Long Sheath
CategoryAccess Device
Description

Long sheath designed for difficult Type III arches, offering best-in-class trackability and tip softness with increased arch support to prevent catheter prolapse.

7pNOVUS Microcatheter
CategoryAccess Device
Description

Microcatheter featuring 14 transition zones for optimized balance and stable coil delivery, a 100cm proprietary coating for navigation through complex anatomy, and a lower profile (2.1F to 1.9F OD) for enhanced compatibility and crossing.

8pORTAL 14 Microguidewire
CategoryAccess Device
Description

Steerable hydrophilic microguidewire with ASACOR technology for maximum torque transmission, dock-extendable design with atraumatic tip, refined hydrophilic coating for lower vessel friction, seamless transition zones, and minimized whip effect and kink resistance via proprietary core alloy.

9p64 Flow Modulation Device
CategoryAneurysm Treatment Device
Description

Flow modulation device for the treatment of complex intracranial aneurysms and dissections, designed to redirect blood flow while maintaining patency of branch vessels.

10pCONUS Bifurcation Aneurysm Implant
CategoryAneurysm Treatment Device
Description

Bifurcation aneurysm implant intended to treat complex, wide neck intracranial bifurcation aneurysms by providing scaffold support at the aneurysm neck.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Wallaby Medical manufactures Avenir, Esperance, Pilote, and pNOVUS 17 products at their facility in Laguna Hills, CA. These products are then distributed by phenox Inc. in the US market. This is a manufacturing partnership where Wallaby produces devices that phenox distributes.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Viz.ai provides AI-enabled stroke detection and care coordination software that interfaces with neurointerventional workflow. While not a device competitor, it operates in the same stroke-treatment ecosystem and increasingly integrates with the same hospital customers.

TypeDirect peer
Description

Penumbra is a direct competitor in the neurovascular space with its aspiration thrombectomy systems (Penumbra System, RED catheters) for acute ischemic stroke. Both companies compete head-to-head in aspiration-based clot retrieval and share the same neurointerventionalist customer base.

TypeBroad incumbent
Description

Stryker's Neurovascular division offers the Trevo stent retriever and a broader portfolio including Target coils and the Neuroform stent. Stryker is a broad incumbent with significantly larger sales reach that competes with Phenox in mechanical thrombectomy and aneurysm treatment.

4MicroPort NeuroTech
TypeRegional player
Description

MicroPort's neurovascular division (historically including assets from the Aryton acquisition) competes in the Chinese and APAC markets with intracranial stents and revascularization devices, overlapping with Phenox's portfolio in select international geographies.

TypeOthers
Description

Wallaby Medical is Phenox's manufacturing partner (WallabyPhenox DBA) and produces several products Phenox distributes in the US. While not a direct commercial competitor, the operational and strategic interdependence makes it a closely linked counterparty.

TypeEmerging player
Description

Rapid Medical develops adjustable neurovascular devices including the Tigertriever stent retriever and Comaneci device. It competes with Phenox in the ischemic stroke and aneurysm spaces with differentiated adjustable-platform technology.

TypeEmerging player
Description

Anaconda Biomed is developing next-generation stent retrievers ( ANA® device) for acute ischemic stroke. It competes in the same mechanical thrombectomy category as Phenox's pRESET, focused on improving clot retrieval efficacy.

TypeBroad incumbent
Description

Balt is an established neurovascular company offering a broad portfolio of coils, stents, flow diverters, and access devices. It competes with Phenox across multiple categories, particularly in European and international markets.

TypeBroad incumbent
Description

Medtronic's neurovascular portfolio includes the Solitaire stent retriever, Pipeline flow diverter, and a full stroke care suite. As a large incumbent with bundled hospital contracts, Medtronic competes with Phenox across multiple device categories.

TypeBroad incumbent
Description

Cerenovus, J&J's neurovascular franchise, offers the Embotrap stent retriever, Galaxy coils, and a complete stroke intervention portfolio. It directly competes with Phenox in thrombectomy, coiling, and access devices.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phenox Inc

Neurovascular Medical Devicesphenox.com

Phenox Inc. is the US distribution arm of phenox GmbH, a privately-held medical device company that develops and sells a portfolio of neurovascular interventional devices — including mechanical thrombectomy, aspiration catheters, embolic coils, and access devices — directly to hospitals and endovascular specialists for treating ischemic and hemorrhagic stroke.

What Phenox Inc does

Phenox Inc. is the US distribution subsidiary of phenox GmbH, a privately-held medical device company founded in 2005 and headquartered in Bochum, Germany. The company develops and distributes interventional devices for the treatment of neurovascular diseases, with a particular focus on acute ischemic stroke, hemorrhagic stroke, and complex intracranial aneurysms. Its US operations are headquartered in Irvine, California, with manufacturing executed through two partners: Wallaby Medical in Laguna Hills, California (producing Avenir, Esperance, Pilote, and pNOVUS 17) and phenox Limited in Galway, Ireland (producing pRESET, pNOVUS 21, and pORTAL).

The product portfolio is structured as an integrated treatment ecosystem across three clinical categories. Acute ischemic stroke devices include the pRESET mechanical thrombectomy device (helical slit design with dual-type cells for clot integration) and the Esperance Aspiration Catheter. Hemorrhagic stroke is addressed via the Avenir Coil System and Avenir Uno (handle-free detachment, 62 ultra-soft coil sizes). Access and delivery devices — pNOVUS Microcatheter, pORTAL 14 Microguidewire (ASACOR torque technology), Pilote Long Sheath, and Esperance Distal Access Catheter — are designed for navigation in tortuous anatomies. Aneurysm treatment is supported by the p64 Flow Modulation Device and pCONUS Bifurcation Aneurysm Implant.

Phenox generates revenue through direct hardware sales of these devices to hospitals, stroke treatment centers, and endovascular specialists, with distribution in the United States handled exclusively through phenox Inc. The company employs an enterprise field sales motion, supported by marketing activity at medical conferences and industry events, and operates alongside affiliated entities under the "WallabyPhenox" brand umbrella.

Phenox Inc firmographics

Firmographics
Name
Phenox Inc
Legal name
phenox Inc.
Website
https://phenox.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
Phenox Inc. is the US distribution arm of phenox GmbH, a privately-held medical device company that develops and sells a portfolio of neurovascular interventional devices — including mechanical thrombectomy, aspiration catheters, embolic coils, and access devices — directly to hospitals and endovascular specialists for treating ischemic and hemorrhagic stroke.
Ownership category
akta.pro rank

Phenox Inc industry classification

Industry
Product category
Neurovascular Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAKAIAG
Stroke & Vascular Neurology

Keywords

  • Neurovascular medical devices
  • Mechanical thrombectomy devices
  • Embolization coil systems
  • Stroke treatment devices
  • Microcatheter access devices

Where Phenox Inc is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Phenox Inc business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Neurovascular Medical Device Sales: Phenox generates revenue through the sale of medical devices for treating neurovascular diseases including thrombectomy devices, aneurysm implants, aspiration catheters, microcatheters, and guidewires. Products are sold to hospitals and endovascular specialists performing stroke procedures.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Phenox Inc product offering

Product offering

Core offering

Phenox develops, manufactures, and distributes neurovascular interventional devices for the treatment of ischemic and hemorrhagic stroke, intracranial aneurysms, and dissections. The portfolio includes mechanical thrombectomy devices (pRESET), aspiration catheters (Esperance), embolic coil systems (Avenir, Avenir Uno), flow modulation and bifurcation implants (p64, pCONUS), and access/delivery devices (pNOVUS, pORTAL, Pilote, Esperance Distal Access Catheter). Products are sold to hospitals and endovascular specialists performing neurovascular procedures.

Product overview

Phenox Inc is a medical device company specializing in neurovascular treatments for stroke. The product portfolio consists of a comprehensive suite of interventional devices organized into three main categories: Acute Ischemic Stroke Devices (thrombectomy and aspiration catheters including pRESET and Esperance Aspiration Catheter), Hemorrhagic Stroke Devices (coiling systems including Avenir Coil System and Avenir Uno), and Access Devices (microcatheters, microguidewires, and sheaths including pNOVUS, pORTAL, Pilote Long Sheath, and Esperance Distal Access Catheter). Additionally, the company offers advanced aneurysm treatment devices including the p64 Flow Modulation Device and pCONUS Bifurcation Aneurysm Implant. These devices work together as an integrated treatment ecosystem where access devices facilitate navigation to treatment sites, and treatment devices address the specific stroke pathology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Esperance Aspiration Catheter Aspiration catheter designed for acute ischemic stroke treatment, used by endovascular specialists to remove blood clots from cerebral arteries through suction-based thrombectomy procedures.
  • pRESET Thrombectomy Device Mechanical thrombectomy device with a helical slit design, proximal closed ring, and dual type cells for clot integration and retrieval in tortuous anatomies, used for acute ischemic stroke treatment.
  • Avenir Coil System Embolic coil system for aneurysm treatment featuring a handle-free instant detachment mechanism, ultra soft coils with 62 sizes of unparalleled softness, a complete portfolio of 7 versatile softness classes, 2 shapes, and 2 coil diameters.
  • Avenir Uno Embolic Coils Embolic coils designed for small diameters and longer lengths, featuring purpose-built precision coil shapes, finisher softness for dense packing, and procedural efficiency in small spaces.
  • Esperance Distal Access Catheter Distal access catheter for accessing cerebral vasculature during neurovascular procedures, providing support and trackability for device delivery.
  • Pilote Long Sheath Long sheath designed for difficult Type III arches, offering best-in-class trackability and tip softness with increased arch support to prevent catheter prolapse.
  • pNOVUS Microcatheter Microcatheter featuring 14 transition zones for optimized balance and stable coil delivery, a 100cm proprietary coating for navigation through complex anatomy, and a lower profile (2.1F to 1.9F OD) for enhanced compatibility and crossing.
  • pORTAL 14 Microguidewire Steerable hydrophilic microguidewire with ASACOR technology for maximum torque transmission, dock-extendable design with atraumatic tip, refined hydrophilic coating for lower vessel friction, seamless transition zones, and minimized whip effect and kink resistance via proprietary core alloy.
  • p64 Flow Modulation Device Flow modulation device for the treatment of complex intracranial aneurysms and dissections, designed to redirect blood flow while maintaining patency of branch vessels.
  • pCONUS Bifurcation Aneurysm Implant Bifurcation aneurysm implant intended to treat complex, wide neck intracranial bifurcation aneurysms by providing scaffold support at the aneurysm neck.

Companies that use Phenox Inc

Customer profile

Segments2 records

Ideal customer profiles2 records

Phenox Inc technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Phenox Inc partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Wallaby MedicalcoreOEM/ Whitelabel/ Licensing PartnerWallaby Medical manufactures Avenir, Esperance, Pilote, and pNOVUS 17 products at their facility in Laguna Hills, CA. These products are then distributed by phenox Inc. in the US market. This is a manufacturing partnership where Wallaby produces devices that phenox distributes.

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Phenox Inc competitors and assessment

Company assessment

Emerging players

  • Viz.ai: Viz.ai provides AI-enabled stroke detection and care coordination software that interfaces with neurointerventional workflow. While not a device competitor, it operates in the same stroke-treatment ecosystem and increasingly integrates with the same hospital customers.
  • Rapid Medical: Rapid Medical develops adjustable neurovascular devices including the Tigertriever stent retriever and Comaneci device. It competes with Phenox in the ischemic stroke and aneurysm spaces with differentiated adjustable-platform technology.
  • Anaconda Biomed: Anaconda Biomed is developing next-generation stent retrievers ( ANA® device) for acute ischemic stroke. It competes in the same mechanical thrombectomy category as Phenox's pRESET, focused on improving clot retrieval efficacy.

Direct peers

  • Penumbra, Inc. Penumbra is a direct competitor in the neurovascular space with its aspiration thrombectomy systems (Penumbra System, RED catheters) for acute ischemic stroke. Both companies compete head-to-head in aspiration-based clot retrieval and share the same neurointerventionalist customer base.

Broad incumbents

  • Stryker (Neurovascular): Stryker's Neurovascular division offers the Trevo stent retriever and a broader portfolio including Target coils and the Neuroform stent. Stryker is a broad incumbent with significantly larger sales reach that competes with Phenox in mechanical thrombectomy and aneurysm treatment.
  • Balt Group: Balt is an established neurovascular company offering a broad portfolio of coils, stents, flow diverters, and access devices. It competes with Phenox across multiple categories, particularly in European and international markets.
  • Medtronic (Neurovascular): Medtronic's neurovascular portfolio includes the Solitaire stent retriever, Pipeline flow diverter, and a full stroke care suite. As a large incumbent with bundled hospital contracts, Medtronic competes with Phenox across multiple device categories.
  • Johnson & Johnson (Cerenovus): Cerenovus, J&J's neurovascular franchise, offers the Embotrap stent retriever, Galaxy coils, and a complete stroke intervention portfolio. It directly competes with Phenox in thrombectomy, coiling, and access devices.

Regional players

  • MicroPort NeuroTech: MicroPort's neurovascular division (historically including assets from the Aryton acquisition) competes in the Chinese and APAC markets with intracranial stents and revascularization devices, overlapping with Phenox's portfolio in select international geographies.

Others

  • Wallaby Medical: Wallaby Medical is Phenox's manufacturing partner (WallabyPhenox DBA) and produces several products Phenox distributes in the US. While not a direct commercial competitor, the operational and strategic interdependence makes it a closely linked counterparty.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Phenox Inc social profiles

Digital presence

Phenox Inc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phenox Inc leadership team

Management profile

Number of profiles

Phenox Inc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phenox Inc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phenox Inc

What does Phenox Inc do?

Phenox develops, manufactures, and distributes neurovascular interventional devices for the treatment of ischemic and hemorrhagic stroke, intracranial aneurysms, and dissections. The portfolio includes mechanical thrombectomy devices (pRESET), aspiration catheters (Esperance), embolic coil systems (Avenir, Avenir Uno), flow modulation and bifurcation implants (p64, pCONUS), and access/delivery devices (pNOVUS, pORTAL, Pilote, Esperance Distal Access Catheter). Products are sold to hospitals and endovascular specialists performing neurovascular procedures.

Is Phenox Inc a public or private company?

Phenox Inc is a private company. It is classified as corporate owned and is currently operating.

When was Phenox Inc founded?

Phenox Inc was founded in 2005. It employs 51 to 100 people.

Where is Phenox Inc based?

Phenox Inc is headquartered in Irvine, United States, in the North America region.

How does Phenox Inc make money?

One revenue line is on record: neurovascular Medical Device Sales.

Who are Phenox Inc's main competitors?

Emerging players on record are Viz.ai, Rapid Medical and Anaconda Biomed. Penumbra, Inc. is listed as a direct peer. Broad incumbents are Stryker (Neurovascular), Balt Group, Medtronic (Neurovascular) and Johnson & Johnson (Cerenovus). MicroPort NeuroTech is listed as a regional player. Wallaby Medical is listed as an others.

Does Phenox Inc have an API?

No public API is recorded for Phenox Inc.

What industry is Phenox Inc in?

Phenox Inc's product category is Neurovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAKAIAG, Stroke & Vascular Neurology. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales